Mayne Pharma Inc recalls Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-2…
- Recall date
- March 21, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0616-2018
- FDA classification
- Class III
- Brand / firm
- Mayne Pharma Inc
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.
Get recall alerts
Free email alert whenever Mayne Pharma Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mayne Pharma Inc